Skip to content

Alkermes ALKS Other Non-Current Liabilities

Other Non-Current Liabilities at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$4.85B+8.4%
Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
$161.5M+77.2%
AbbVie logo
AbbVieABBV
$34.11B+9.4%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$28.27M-49.2%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
$260.9M+43.7%
ALN
Alnylam PharmaceuticalsALNY

Other financials

Income statement

See full
Revenue$392.9M+28.2%
Gross profit$331.3M+28.8%
Operating income-$48.3M-450%
Net income-$66.5M-396%
EPS (diluted)-$0.40-408%

Balance sheet

See full
Cash & equivalents$351.6M-12.1%
Total debt$1.6B+2,034%
Total equity$1.8B+15.9%
Total assets$4.3B+105%

Cash flow

See full
Operating cash flow-$165.7M-268%
CapEx$4.1M-59.5%
Free cash flow-$169.8M-291%

Valuation

See full
Market cap$7.5B+9.7%
Enterprise value$8.73B+41.2%
P/E49.1×+29.7×
P/S4.8×+0.3×

Profitability

See full
Gross margin86.6%+2.2pp
Operating margin12.3%-13.6pp
Net margin9.8%-13.5pp
FCF margin14.2%-17.6pp

Returns & leverage

See full
Return on equity9.4%-16.1pp
Debt / equity0.9×+0.9×
Current ratio2.3×-1.1×

Where this comes from

Reported directly by Alkermes in its filing.

Tagged under the XBRL concept us-gaap:OtherLiabilitiesNoncurrent.

The official record: Alkermes’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alkermes's other non-current liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Alkermes's other non-current liabilities?
Alkermes (ALKS) reported other non-current liabilities of $68.05M in Q1 2026.
How has Alkermes's other non-current liabilities changed year-over-year?
Alkermes's other non-current liabilities increased by 15.6% year-over-year, from $58.85M to $68.05M.
What is the long-term trend for Alkermes's other non-current liabilities?
Over 5 years (2020 to 2025), Alkermes's other non-current liabilities has grown at a 10.8% compound annual growth rate (CAGR), from $36.51M to $61.01M.
What does other non-current liabilities mean?
Miscellaneous long-term financial obligations not categorized elsewhere.
How do you interpret other non-current liabilities?
A significant increase may signal rising long-term risks, such as litigation reserves or pension funding requirements.
How does other non-current liabilities compare across companies?
Varies widely across the industry based on specific legal, pension, and tax structures of individual firms.